Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus
- 1 December 1998
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 115 (6) , 1381-1386
- https://doi.org/10.1016/s0016-5085(98)70016-2
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Cancer Cell CyclesScience, 1996
- Frequency of homozygous deletion at p16/CDKN2 in primary human tumoursNature Genetics, 1995
- Intragenic mutations of CDKN2B and CDKN2A in primary human esophageal cancersHuman Molecular Genetics, 1995
- Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinomaNature Genetics, 1994
- pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrestNature, 1994
- Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colonNature Genetics, 1994
- Rates of p16 ( MTS1 ) Mutations in Primary Tumors with 9p LossScience, 1994
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor TypesScience, 1994
- Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancersNature, 1994
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993